260 related articles for article (PubMed ID: 31444910)
1. Evidence for central antispastic effect of botulinum toxin type A.
Matak I
Br J Pharmacol; 2020 Jan; 177(1):65-76. PubMed ID: 31444910
[TBL] [Abstract][Full Text] [Related]
2. Lasting Peripheral and Central Effects of Botulinum Toxin Type A on Experimental Muscle Hypertonia in Rats.
Šoštarić P; Vukić B; Tomašić L; Matak I
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36232926
[TBL] [Abstract][Full Text] [Related]
3. Beyond neuromuscular activity: botulinum toxin type A exerts direct central action on spinal control of movement.
Šoštarić P; Matić M; Nemanić D; Lučev Vasić Ž; Cifrek M; Pirazzini M; Matak I
Eur J Pharmacol; 2024 Jan; 962():176242. PubMed ID: 38048980
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin type a antinociceptive activity in trigeminal regions involves central transcytosis.
Nemanić D; Mustapić M; Matak I; Bach-Rojecky L
Eur J Pharmacol; 2024 Jan; 963():176279. PubMed ID: 38123005
[TBL] [Abstract][Full Text] [Related]
5. Botulinum neurotoxins A and E undergo retrograde axonal transport in primary motor neurons.
Restani L; Giribaldi F; Manich M; Bercsenyi K; Menendez G; Rossetto O; Caleo M; Schiavo G
PLoS Pathog; 2012 Dec; 8(12):e1003087. PubMed ID: 23300443
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin type A selectivity for certain types of pain is associated with capsaicin-sensitive neurons.
Matak I; Rossetto O; Lacković Z
Pain; 2014 Aug; 155(8):1516-1526. PubMed ID: 24793910
[TBL] [Abstract][Full Text] [Related]
7. The Effects of Botulinum Toxin Injections on Spasticity and Motor Performance in Chronic Stroke with Spastic Hemiplegia.
Chen YT; Zhang C; Liu Y; Magat E; Verduzco-Gutierrez M; Francisco GE; Zhou P; Zhang Y; Li S
Toxins (Basel); 2020 Jul; 12(8):. PubMed ID: 32751970
[TBL] [Abstract][Full Text] [Related]
8. Transynaptic Action of Botulinum Neurotoxin Type A at Central Cholinergic Boutons.
Caleo M; Spinelli M; Colosimo F; Matak I; Rossetto O; Lackovic Z; Restani L
J Neurosci; 2018 Nov; 38(48):10329-10337. PubMed ID: 30315128
[TBL] [Abstract][Full Text] [Related]
9. Is spastic muscle echo intensity related to the response to botulinum toxin type A in patients with stroke? A cohort study.
Picelli A; Bonetti P; Fontana C; Barausse M; Dambruoso F; Gajofatto F; Girardi P; Manca M; Gimigliano R; Smania N
Arch Phys Med Rehabil; 2012 Jul; 93(7):1253-8. PubMed ID: 22502807
[TBL] [Abstract][Full Text] [Related]
10. Quantitative evaluation for spasticity of calf muscle after botulinum toxin injection in patients with cerebral palsy: a pilot study.
Lin YC; Lin IL; Chou TF; Lee HM
J Neuroeng Rehabil; 2016 Mar; 13():25. PubMed ID: 26969526
[TBL] [Abstract][Full Text] [Related]
11. More than at the neuromuscular synapse: actions of botulinum neurotoxin A in the central nervous system.
Mazzocchio R; Caleo M
Neuroscientist; 2015 Feb; 21(1):44-61. PubMed ID: 24576870
[TBL] [Abstract][Full Text] [Related]
12. How muscles recover from paresis and atrophy after intramuscular injection of botulinum toxin A: Study in juvenile rats.
Shen J; Ma J; Lee C; Smith BP; Smith TL; Tan KH; Koman LA
J Orthop Res; 2006 May; 24(5):1128-35. PubMed ID: 16602109
[TBL] [Abstract][Full Text] [Related]
13. Involvement of substance P in the antinociceptive effect of botulinum toxin type A: Evidence from knockout mice.
Matak I; Tékus V; Bölcskei K; Lacković Z; Helyes Z
Neuroscience; 2017 Sep; 358():137-145. PubMed ID: 28673722
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin's axonal transport from periphery to the spinal cord.
Matak I; Riederer P; Lacković Z
Neurochem Int; 2012 Jul; 61(2):236-9. PubMed ID: 22580329
[TBL] [Abstract][Full Text] [Related]
15. Muscle volume alterations in spastic muscles immediately following botulinum toxin type-A treatment in children with cerebral palsy.
Williams SA; Reid S; Elliott C; Shipman P; Valentine J
Dev Med Child Neurol; 2013 Sep; 55(9):813-20. PubMed ID: 23789782
[TBL] [Abstract][Full Text] [Related]
16. Beyond muscular effects: depression of spinal recurrent inhibition after botulinum neurotoxin A.
Marchand-Pauvert V; Aymard C; Giboin LS; Dominici F; Rossi A; Mazzocchio R
J Physiol; 2013 Feb; 591(4):1017-29. PubMed ID: 23045348
[TBL] [Abstract][Full Text] [Related]
17. Activity of botulinum toxin type A in cranial dura: implications for treatment of migraine and other headaches.
Lacković Z; Filipović B; Matak I; Helyes Z
Br J Pharmacol; 2016 Jan; 173(2):279-91. PubMed ID: 26493010
[TBL] [Abstract][Full Text] [Related]
18. Combining strength training and botulinum neurotoxin intervention in children with cerebral palsy: the impact on muscle morphology and strength.
Williams SA; Elliott C; Valentine J; Gubbay A; Shipman P; Reid S
Disabil Rehabil; 2013 Apr; 35(7):596-605. PubMed ID: 22928803
[TBL] [Abstract][Full Text] [Related]
19. Effects of ultrasound-guided botulinum toxin type-A injections with a specific approach in spastic cerebral palsy.
Büyükavcı R; Büyükavcı MA
Acta Neurol Belg; 2018 Sep; 118(3):429-433. PubMed ID: 29694645
[TBL] [Abstract][Full Text] [Related]
20. Intrafusal effects of botulinum toxin injections for spasticity: revisiting a previous paper.
Phadke CP; On AY; Kirazli Y; Ismail F; Boulias C
Neurosci Lett; 2013 Apr; 541():20-3. PubMed ID: 23458671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
